232 related articles for article (PubMed ID: 32655635)
21. Anemia and the heart in chronic kidney disease.
Zalunardo N; Levin A
Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
[TBL] [Abstract][Full Text] [Related]
22. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Involvement in Patients with Chronic Kidney Disease.
Bhattacharya A; Rana K; Vanpariya N; Roy R; Radadiya T; Singh S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443397
[TBL] [Abstract][Full Text] [Related]
24. Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment.
Di Lullo L; Gorini A; Russo D; Santoboni A; Ronco C
Cardiorenal Med; 2015 Oct; 5(4):254-66. PubMed ID: 26648942
[TBL] [Abstract][Full Text] [Related]
25. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease in patients with chronic kidney disease.
Jaradat MI; Molitoris BA
Semin Nephrol; 2002 Nov; 22(6):459-73. PubMed ID: 12430090
[TBL] [Abstract][Full Text] [Related]
27. Assessment of some cardiovascular risk factors in predialysis chronic kidney disease patients in Southern Nigeria.
Adejumo OA; Okaka EI; Madumezia G; Okwuonu CG; Ojogwu LI
Niger Med J; 2015; 56(6):394-9. PubMed ID: 26903696
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD).
Hruska KA; Choi ET; Memon I; Davis TK; Mathew S
Pediatr Nephrol; 2010 Apr; 25(4):769-78. PubMed ID: 19898875
[TBL] [Abstract][Full Text] [Related]
29. Masked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events.
Babu M; Drawz P
Curr Cardiol Rep; 2019 May; 21(7):58. PubMed ID: 31111326
[TBL] [Abstract][Full Text] [Related]
30. [Risk factors for cardiovascular system damage in chronic kidney disease].
Kutyrina IM; Rudenko TE; Savel'eva SA; Shvetsov MIu; Vasil'eva MP
Ter Arkh; 2013; 85(9):69-76. PubMed ID: 24261233
[TBL] [Abstract][Full Text] [Related]
31. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
[TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease and cardiovascular disease: pathophysiologic links.
Burrows L; Muller R
Nephrol Nurs J; 2007; 34(1):55-63; quiz 64-5. PubMed ID: 17345692
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association.
Zoccali C; Mallamaci F; Adamczak M; de Oliveira RB; Massy ZA; Sarafidis P; Agarwal R; Mark PB; Kotanko P; Ferro CJ; Wanner C; Burnier M; Vanholder R; Wiecek A
Cardiovasc Res; 2023 Sep; 119(11):2017-2032. PubMed ID: 37249051
[TBL] [Abstract][Full Text] [Related]
35. Risk of stroke in kidney disease.
Ninomiya T
Contrib Nephrol; 2013; 179():58-66. PubMed ID: 23652449
[TBL] [Abstract][Full Text] [Related]
36. [FGF23 and the heart].
Ezumba I; Quarles LD; Kovesdy CP
G Ital Nefrol; 2014; 31(6):. PubMed ID: 25504170
[TBL] [Abstract][Full Text] [Related]
37. [Epidemiology of cardiovascular disease in CKD-MBD].
Di Micco L; Mozzillo GR; Cianciaruso B
G Ital Nefrol; 2009; 26 Suppl 49():S3-10. PubMed ID: 19941272
[TBL] [Abstract][Full Text] [Related]
38. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis.
Levin A
Semin Dial; 2003; 16(2):101-5. PubMed ID: 12641872
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
Ruebner RL; Ng D; Mitsnefes M; Foster BJ; Meyers K; Warady B; Furth SL
Clin J Am Soc Nephrol; 2016 Nov; 11(11):1962-1968. PubMed ID: 27630183
[TBL] [Abstract][Full Text] [Related]
40. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
Ulasi II; Arodiwe EB; Ijoma CK
Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
